| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0960-9822(99)80047-5 |
| P698 | PubMed publication ID | 9889125 |
| P2093 | author name string | Brown R | |
| Borts RH | |||
| Morris MM | |||
| McCormick C | |||
| Hirst GL | |||
| Durant ST | |||
| Illand M | |||
| McKay HJ | |||
| P2860 | cites work | Holliday junctions accumulate in replication mutants via a RecA homolog-independent mechanism | Q27929886 |
| Role of the Rad1 and Rad10 proteins in nucleotide excision repair and recombination. | Q27931636 | ||
| Role of Saccharomyces cerevisiae Msh2 and Msh3 repair proteins in double-strand break-induced recombination | Q27931976 | ||
| The HMG-domain protein Ixr1 blocks excision repair of cisplatin-DNA adducts in yeast | Q27932242 | ||
| Biochemistry and genetics of eukaryotic mismatch repair | Q28282377 | ||
| The distribution of the numbers of mutants in bacterial populations | Q29620123 | ||
| Selective recognition of a cisplatin-DNA adduct by human mismatch repair proteins. | Q34625095 | ||
| Differential human nucleotide excision repair of paired and mispaired cisplatin-DNA adducts | Q34625375 | ||
| Dual roles for DNA sequence identity and the mismatch repair system in the regulation of mitotic crossing-over in yeast | Q36574453 | ||
| Dual requirement in yeast DNA mismatch repair for MLH1 and PMS1, two homologs of the bacterial mutL gene | Q36643609 | ||
| Mlh1 is unique among mismatch repair proteins in its ability to promote crossing-over during meiosis | Q38344945 | ||
| Cisplatin and DNA repair in cancer chemotherapy | Q40930064 | ||
| hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agents | Q41100219 | ||
| Strand-specific mismatch repair in mammalian cells | Q41602506 | ||
| Isolation and characterization of yeast DNA repair genes : I. Cloning of the RAD52 gene. | Q46025581 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | DNA mismatch repair | Q2984243 |
| drug resistance | Q12147416 | ||
| P304 | page(s) | 51-54 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | Current Biology | Q1144851 |
| P1476 | title | Dependence on RAD52 and RAD1 for anticancer drug resistance mediated by inactivation of mismatch repair genes. | |
| P478 | volume | 9 |
| Q40811043 | A role for mismatch repair in control of DNA ploidy following DNA damage |
| Q24564010 | ATM-mediated stabilization of hMutL DNA mismatch repair proteins augments p53 activation during DNA damage |
| Q74297565 | Alteration in the choice of DNA repair pathway with increasing sequence selective DNA alkylation in the minor groove |
| Q36291554 | Apoptosome activation, an important molecular instigator in 6-mercaptopurine induced Leydig cell death. |
| Q37775585 | Assessing the link between BACH1/FANCJ and MLH1 in DNA crosslink repair |
| Q40720210 | Association of p53 and MSH2 with recombinative repair complexes during S phase |
| Q53331560 | Clinical significance of microsatellite instability in endometrial carcinoma. |
| Q33463362 | Comparative genome-wide screening identifies a conserved doxorubicin repair network that is diploid specific in Saccharomyces cerevisiae |
| Q40806587 | Concerted action of the MutLβ heterodimer and Mer3 helicase regulates the global extent of meiotic gene conversion. |
| Q38981181 | Crosstalk between BRCA-Fanconi anemia and mismatch repair pathways prevents MSH2-dependent aberrant DNA damage responses |
| Q28709604 | DNA repair mechanisms and the bypass of DNA damage in Saccharomyces cerevisiae |
| Q27934236 | Discrete in vivo roles for the MutL homologs Mlh2p and Mlh3p in the removal of frameshift intermediates in budding yeast |
| Q36952570 | Dysregulation of purine nucleotide biosynthesis pathways modulates cisplatin cytotoxicity in Saccharomyces cerevisiae |
| Q57072621 | Functional Interaction Between and DNA Repair in Yeast May Uncover a Role of , and Somatic Variants in Cancer Development |
| Q27939611 | Functional specificity of MutL homologs in yeast: evidence for three Mlh1-based heterocomplexes with distinct roles during meiosis in recombination and mismatch correction |
| Q34049228 | Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer. |
| Q35318165 | Heteroduplex rejection during single-strand annealing requires Sgs1 helicase and mismatch repair proteins Msh2 and Msh6 but not Pms1 |
| Q40070246 | Identification of genes required for protection from doxorubicin by a genome-wide screen in Saccharomyces cerevisiae |
| Q38868797 | Low-fidelity alternative DNA repair carcinogenesis theory may interpret many cancer features and anticancer strategies |
| Q24810372 | MSH2 missense mutations alter cisplatin cytotoxicity and promote cisplatin-induced genome instability |
| Q43829355 | Mechanisms of tolerance to DNA damaging therapeutic drugs |
| Q34194518 | Mismatch repair in correction of replication errors and processing of DNA damage |
| Q46727121 | Mismatch repair regulates homologous recombination, but has little influence on antigenic variation, in Trypanosoma brucei |
| Q35165645 | Mlh2 is an accessory factor for DNA mismatch repair in Saccharomyces cerevisiae |
| Q35758048 | Molecular mechanisms of resistance and toxicity associated with platinating agents |
| Q40601230 | Msh2 deficiency does not contribute to cisplatin resistance in mouse embryonic stem cells |
| Q64388676 | Multiple pathways of recombination define cellular responses to cisplatin |
| Q27012444 | Nuclear export of proteins and drug resistance in cancer |
| Q34343361 | Repair of DNA interstrand cross-links |
| Q39452783 | Repair of intermediate structures produced at DNA interstrand cross-links in Saccharomyces cerevisiae |
| Q35910747 | Role of DNA mismatch repair in apoptotic responses to therapeutic agents |
| Q40865504 | Spontaneous development of drug resistance: mismatch repair and p53 defects in resistance to cisplatin in human tumor cells |
| Q35567287 | Strategies for reversing drug resistance |
| Q37408350 | Structure-activity relationship (SAR) and preliminary mode of action studies of 3-substituted benzylthioquinolinium iodide as anti-opportunistic infection agents |
| Q24596494 | The interacting domains of three MutL heterodimers in man: hMLH1 interacts with 36 homologous amino acid residues within hMLH3, hPMS1 and hPMS2 |
| Q33984289 | The many faces of mismatch repair in meiosis |
| Q37153771 | The mismatch repair system promotes DNA polymerase zeta-dependent translesion synthesis in yeast. |
| Q39936122 | Vanillins--a novel family of DNA-PK inhibitors |
| Q36186819 | What is wrong with Fanconi anemia cells? |
| Q24292731 | XPA versus ERCC1 as chemosensitising agents to cisplatin and mitomycin C in prostate cancer cells: role of ERCC1 in homologous recombination repair |
| Q39791125 | XPF-ERCC1 participates in the Fanconi anemia pathway of cross-link repair. |
Search more.